Dimerix Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported net loss was AUD 6.67 million compared to AUD 9.61 million a year ago. Basic loss per share from continuing operations was AUD 0.01645 compared to AUD 0.02995 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.51 AUD | +7.37% |
|
+15.91% | +148.78% |
Jul. 04 | Dimerix to Recruit Adolescents for Kidney Drug Study; Shares Decline 7% | MT |
May. 29 | Euroz Hartleys Adjusts Dimerix’s Price Target to AU$0.86 From AU$0.80, Keeps at Speculative Buy | MT |
1st Jan change | Capi. | |
---|---|---|
+148.78% | 177M | |
+22.15% | 46.56B | |
+45.21% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix Limited Reports Earnings Results for the Half Year Ended December 31, 2023